Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1984 1
1985 2
1986 3
1988 1
1989 1
1990 2
1991 3
1992 2
1993 5
1994 2
1995 1
1996 2
1997 5
1998 5
1999 6
2000 4
2001 3
2002 3
2003 4
2004 5
2005 2
2006 6
2007 6
2008 7
2009 9
2010 10
2011 4
2012 5
2013 13
2014 11
2015 4
2016 2
2017 4
2018 4
2019 4
2020 4
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
The additive effect of vitamin K supplementation and bisphosphonate on fracture risk in post-menopausal osteoporosis: a randomised placebo controlled trial.
Moore AE, Dulnoan D, Voong K, Ayis S, Mangelis A, Gorska R, Harrington DJ, Tang JCY, Fraser WD, Hampson G. Moore AE, et al. Arch Osteoporos. 2023 Jun 20;18(1):83. doi: 10.1007/s11657-023-01288-w. Arch Osteoporos. 2023. PMID: 37338608 Free PMC article. Clinical Trial.
No difference in bone density or bone turnover was observed although vitamin K(1) supplementation led to a modest effect on parameters of hip geometry. ...METHODS: We conducted a trial in 105 women aged 68.7[12.3] years with PMO and serum vitamin K
No difference in bone density or bone turnover was observed although vitamin K(1) supplementation led to a modest effec …
Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial.
Holden RM, Booth SL, Zimmerman D, Moist L, Norman PA, Day AG, Menard A, Fu X, Shea MK, Babiolakis CS, Nolan R, Turner ME, Ward E, Kaufmann M, Adams MA, Heyland DK. Holden RM, et al. Nephrol Dial Transplant. 2023 Feb 28;38(3):746-756. doi: 10.1093/ndt/gfac191. Nephrol Dial Transplant. 2023. PMID: 35641194 Free PMC article. Clinical Trial.
Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D. Lubetsky A, et al. Arch Intern Med. 2003 Nov 10;163(20):2469-73. doi: 10.1001/archinte.163.20.2469. Arch Intern Med. 2003. PMID: 14609783 Clinical Trial.
BACKGROUND: Treatment of patients with excessive anticoagulation is routinely done by intravenous phytonadione (vitamin K1). Oral administration of phytonadione has been shown to be an effective alternative to the intravenous route, but these methods have never been …
BACKGROUND: Treatment of patients with excessive anticoagulation is routinely done by intravenous phytonadione (vitamin K1). Oral adm …
Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione.
Raj G, Kumar R, McKinney WP. Raj G, et al. Arch Intern Med. 1999 Dec 13-27;159(22):2721-4. doi: 10.1001/archinte.159.22.2721. Arch Intern Med. 1999. PMID: 10597763 Clinical Trial.
BACKGROUND: Excessive anticoagulation increases the risk of hemorrhagic complications associated with oral anticoagulant therapy. Oral or parenteral phytonadione is used to reverse excessive anticoagulation. Intravenous (IV) phytonadione, while effective, is associa …
BACKGROUND: Excessive anticoagulation increases the risk of hemorrhagic complications associated with oral anticoagulant therapy. Oral or pa …
Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio.
Byrd DC, Stephens MA, Hamann GL, Dorko C. Byrd DC, et al. Am J Health Syst Pharm. 1999 Nov 15;56(22):2312-5. doi: 10.1093/ajhp/56.22.2312. Am J Health Syst Pharm. 1999. PMID: 10582823 Clinical Trial.
The efficacy and safety of subcutaneous phytonadione in the treatment of patients with asymptomatic excessive International Normalized Ratio (INR) values secondary to warfarin therapy were evaluated. ...No patients reported hemorrhagic or thrombotic complications. Subcutan …
The efficacy and safety of subcutaneous phytonadione in the treatment of patients with asymptomatic excessive International Normalize …
Dietary intake of vitamin K is inversely associated with mortality risk.
Juanola-Falgarona M, Salas-Salvadó J, Martínez-González MÁ, Corella D, Estruch R, Ros E, Fitó M, Arós F, Gómez-Gracia E, Fiol M, Lapetra J, Basora J, Lamuela-Raventós RM, Serra-Majem L, Pintó X, Muñoz MÁ, Ruiz-Gutiérrez V, Fernández-Ballart J, Bulló M. Juanola-Falgarona M, et al. J Nutr. 2014 May;144(5):743-50. doi: 10.3945/jn.113.187740. Epub 2014 Mar 19. J Nutr. 2014. PMID: 24647393 Free article. Clinical Trial.
A simple, sensitive, and high-throughput LC-APCI-MS/MS method for simultaneous determination of vitamin K(1), vitamin K(1) 2,3-epoxide in human plasma and its application to a clinical pharmacodynamic study of warfarin.
Hu K, Li Y, Ding R, Zhai Y, Chen L, Qian W, Yang J. Hu K, et al. J Pharm Biomed Anal. 2018 Sep 10;159:82-91. doi: 10.1016/j.jpba.2018.06.041. Epub 2018 Jun 23. J Pharm Biomed Anal. 2018. PMID: 29980023 Clinical Trial.
A quantitative understanding of how warfarin and related genes interact with the vitamin K-epoxide cycle and the associated change of coagulation activity in the human body may help study the pharmacodynamics of warfarin. The plasma concentration of vitamin K(1
A quantitative understanding of how warfarin and related genes interact with the vitamin K-epoxide cycle and the associated change of coagul …
Effect of calcium, vitamins K1 and D3 on bone in galactosemia.
Panis B, Vermeer C, van Kroonenburgh MJPG, Nieman FHM, Menheere PPCA, Spaapen LJ, Rubio-Gozalbo ME. Panis B, et al. Bone. 2006 Nov;39(5):1123-1129. doi: 10.1016/j.bone.2006.05.002. Epub 2006 Jun 19. Bone. 2006. PMID: 16782422 Clinical Trial.
A 2-year randomized, double-blind, placebo-controlled clinical trial was undertaken in which 40 children with classical galactosemia (13 males and 27 females, aged 3-17 years) were included to receive daily either 750 mg calcium, 1.0 mg vitamin K(1) and 10.0 …
A 2-year randomized, double-blind, placebo-controlled clinical trial was undertaken in which 40 children with classical galactosemia (13 mal …
148 results